PDCD1 and non-small cell lung carcinoma: Then, multiple immunofluorescence staining of tumor biopsies before treatment from 14 patients with advanced NSCLC reveals that high endothelial venules (PNAd +) are predictive of better response and survival upon PD-1 inhibitors combined with anti-angiogenesis therapy (P = 0.0274).